| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | ULTRAGENYX PHARMACEUTICAL INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $390,000 | |
| 2026 | ULTRAGENYX PHARMACEUTICAL INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $440,000 | |
| 2025 | ULTRAGENYX PHARMACEUTICAL INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $130,000 | |
| 2025 | ULTRAGENYX PHARMACEUTICAL INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $140,000 | |
| 2025 | ULTRAGENYX PHARMACEUTICAL INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | $140,000 | |
| 2025 | ULTRAGENYX PHARMACEUTICAL INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $330,000 | |
| 2024 | ULTRAGENYX PHARMACEUTICAL INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $110,000 | |
| 2024 | ULTRAGENYX PHARMACEUTICAL INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $80,000 | |
| 2024 | ULTRAGENYX PHARMACEUTICAL INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $30,000 | |
| 2024 | ULTRAGENYX PHARMACEUTICAL INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $220,000 |
| Client | Filings | Total Income |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | 11 | — |
| Name | Disclosed Prior Position |
|---|---|
| LISA KAHLMAN |